Exploration of Targeted Anti-tumor Therapy

Open Access Original Article

Liquid biopsy: an examination of platelet RNA obtained from head and neck squamous cell carcinoma patients for predictive molecular tumor markers

Lisa T. Huber ... Cornelia Brunner

Published: June 30, 2023 Explor Target Antitumor Ther. 2023;4:422–446

DOI: https://doi.org/10.37349/etat.2023.00143

This article belongs to the special issue The Implementation of Liquid Biopsy in Clinical Practice for Different Solid Tumor

Full Text PDF

6258 43 8

Open Access Review

Artificial intelligence and radiomics in magnetic resonance imaging of rectal cancer: a review

Giuseppe Di Costanzo ... Enrico Cavaglià

Published: June 30, 2023 Explor Target Antitumor Ther. 2023;4:406–421

DOI: https://doi.org/10.37349/etat.2023.00142

This article belongs to the special issue Artificial Intelligence for Precision Oncology

Full Text PDF

7005 53 16

Open Access Original Article

Real world outcomes in patients with neuroendocrine tumor receiving peptide receptor radionucleotide therapy

Stijn Hentzen ... Anup Kasi

Published: June 29, 2023 Explor Target Antitumor Ther. 2023;4:396–405

DOI: https://doi.org/10.37349/etat.2023.00141

Full Text PDF

5864 26 6

Open Access Review

Capitalizing glycomic changes for improved biomarker-based cancer diagnostics

Maria Luísa S. Silva

Published: June 28, 2023 Explor Target Antitumor Ther. 2023;4:366–395

DOI: https://doi.org/10.37349/etat.2023.00140

This article belongs to the special issue Biomarkers for Personalized and Precise Cancer Diagnosis and Treatment

Full Text PDF

8487 68 14

Open Access Original Article

Small cell lung cancer: circulating tumor cell lines and expression of mediators of angiogenesis and coagulation

Barbara Rath ... Gerhard Hamilton

Published: April 28, 2023 Explor Target Antitumor Ther. 2023;4:355–365

DOI: https://doi.org/10.37349/etat.2023.00139

Full Text PDF

4023 41 5

Open Access Review

Role of artificial intelligence in oncologic emergencies: a narrative review

Salvatore Claudio Fanni ... Emanuele Neri

Published: April 28, 2023 Explor Target Antitumor Ther. 2023;4:344–354

DOI: https://doi.org/10.37349/etat.2023.00138

This article belongs to the special issue Artificial Intelligence for Precision Oncology

Full Text PDF

5166 55 8

Open Access Review

Transforming growth factor-β signaling: from tumor microenvironment to anticancer therapy

Max Kam-Kwan Chan ... Patrick Ming-Kuen Tang

Published: April 28, 2023 Explor Target Antitumor Ther. 2023;4:316–343

DOI: https://doi.org/10.37349/etat.2023.00137

This article belongs to the special issue Cancer Immunotherapy and Tumor Microenvironment

Full Text PDF

15083 110 35

Open Access Case Report

Complete response to third-line treatment with trifluridine/tipiracil (TAS-102) in stage IV colon adenocarcinoma

Celia Lara-Morga ... Luis Cabezón-Gutiérrez

Published: April 27, 2023 Explor Target Antitumor Ther. 2023;4:307–315

DOI: https://doi.org/10.37349/etat.2023.00136

This article belongs to the special issue Biomarkers for Personalized and Precise Cancer Diagnosis and Treatment

Full Text PDF

5258 32 1

Open Access Original Article

Development and validation of an infrared-artificial intelligence software for breast cancer detection

Enrique Martín-Del-Campo-Mena ... Yessica González-Mejía

Published: April 27, 2023 Explor Target Antitumor Ther. 2023;4:294–306

DOI: https://doi.org/10.37349/etat.2023.00135

This article belongs to the special issue Artificial Intelligence for Precision Oncology

Full Text PDF

8365 88 8

Open Access Systematic Review

Anticancer of genus Syzygium: a systematic review

Mahmoud Dogara Abdulrahman, Harmand A. Hama

Published: April 27, 2023 Explor Target Antitumor Ther. 2023;4:273–293

DOI: https://doi.org/10.37349/etat.2023.00134

This article belongs to the special issue Plant Extracts as an Infinite Resource for New Anticancer Agents

Full Text PDF

9636 133 15

Open Access Case Report

Cystic presentation of primary hepatic neuroendocrine tumour: a case report with a brief review of literature

Mangesh Londhe ... Charusheela Gore

Published: April 26, 2023 Explor Target Antitumor Ther. 2023;4:266–272

DOI: https://doi.org/10.37349/etat.2023.00133

This article belongs to the special issue Precision Medicine for Cholangiocarcinoma

Full Text PDF

4112 20 1

Open Access Review

Gut microbiota, an emergent target to shape the efficiency of cancer therapy

Soumaya Kouidhi ... Amel Ben Ammar El Gaaied

Published: April 26, 2023 Explor Target Antitumor Ther. 2023;4:240–265

DOI: https://doi.org/10.37349/etat.2023.00132

This article belongs to the special issue Cancer Immunotherapy and Tumor Microenvironment

Full Text PDF

9867 129 35

Open Access Original Article

A potent bioactive fraction against colon cancer from Plectranthus vettiveroides

Faisal M. Athikkavil ... Smitha V. Bava

Published: April 24, 2023 Explor Target Antitumor Ther. 2023;4:227–239

DOI: https://doi.org/10.37349/etat.2023.00131

This article belongs to the special issue Plant Extracts as an Infinite Resource for New Anticancer Agents

Full Text PDF

5570 54 4

Open Access Letter to the Editor

Clinicopathological relevance of stem cell marker growth and differentiation factor 3 in esophageal squamous cell carcinoma

Sara Tahbazzadeh Moghaddam, Mohammad Mahdi Forghanifard

Published: April 24, 2023 Explor Target Antitumor Ther. 2023;4:217–226

DOI: https://doi.org/10.37349/etat.2023.00130

Full Text PDF

3387 22 0

Open Access Review

Ginnalin A and hamamelitannin: the unique gallotannins with promising anti-carcinogenic potential

Rippin ... Anil K. Sharma

Published: April 21, 2023 Explor Target Antitumor Ther. 2023;4:208–216

DOI: https://doi.org/10.37349/etat.2023.00129

This article belongs to the special issue Plant Extracts as an Infinite Resource for New Anticancer Agents

Full Text PDF

5925 42 9

Open Access Review

Cancer resistance via the downregulation of the tumor suppressors RKIP and PTEN expressions: therapeutic implications

Matthew Moghaddam ... Benjamin Bonavida

Published: April 20, 2023 Explor Target Antitumor Ther. 2023;4:170–207

DOI: https://doi.org/10.37349/etat.2023.00128

This article belongs to the special issue Cancer Immunotherapy and Tumor Microenvironment

Full Text PDF

7623 50 16

Open Access Review

Artificial intelligence applications in pediatric oncology diagnosis

Yuhan Yang ... Yuan Li

Published: February 28, 2023 Explor Target Antitumor Ther. 2023;4:157–169

DOI: https://doi.org/10.37349/etat.2023.00127

This article belongs to the special issue Artificial Intelligence for Precision Oncology

Full Text PDF

6537 90 25

Open Access Review

Research progress in molecular pathology markers in medulloblastoma

Zixuan Zhou ... Shangfeng Gao

Published: February 28, 2023 Explor Target Antitumor Ther. 2023;4:139–156

DOI: https://doi.org/10.37349/etat.2023.00126

This article belongs to the special issue Theranostic Frontiers in Neuro-Oncology

Full Text PDF

8289 37 5

Open Access Review

Diagnostic value of liquid biopsy in the era of precision medicine: 10 years of clinical evidence in cancer

Vincenza Caputo ... Stefania Napolitano

Published: February 28, 2023 Explor Target Antitumor Ther. 2023;4:102–138

DOI: https://doi.org/10.37349/etat.2023.00125

This article belongs to the special issue The Implementation of Liquid Biopsy in Clinical Practice for Different Solid Tumor

Full Text PDF

16689 202 66

Open Access Review

Macrophages as potential targets in gene therapy for cancer treatment

Yuanzheng Huang ... Xiaoxuan Liu

Published: February 28, 2023 Explor Target Antitumor Ther. 2023;4:89–101

DOI: https://doi.org/10.37349/etat.2023.00124

This article belongs to the special issue Gene Delivery Approach to Fight Cancer

Full Text PDF

7784 74 11